Intragastric device
AssigneeObalon Therapeutics, Inc.
InventorsMark C. Brister, Nelson Quintana, Kaushik A. Patel, Neil R. Drake, Antonio C. Llevares, Dubravka Markovic, Andrew P. Rasdal, Amy D. L. VandenBerg
Life of this patent
Estimating the term…
Loading patent…
AssigneeObalon Therapeutics, Inc.
InventorsMark C. Brister, Nelson Quintana, Kaushik A. Patel, Neil R. Drake, Antonio C. Llevares, Dubravka Markovic, Andrew P. Rasdal, Amy D. L. VandenBerg
Estimating the term…
An implant configured for ingestion by a patient. After the implant has been swallowed by the patient and is disposed within the target location, e.g. the patient's stomach, an inflation subcomponent causes the implant to expand from a compact delivery state to an expanded, volume-occupying, deployed state. In the deployed state the implant creates a sensation of satiety in the patient stomach and thereby aids in limiting food intake and obesity. After a predetermined time a deflation subcomponent is actuated and the implant reduces in size so as to allow it to pass through the remainder of the patient's digestive track. The device may further incorporate tracking and visualization subcomponents, as well as pharmaceutical delivery subcomponents.
A swallowable intragastric balloon system comprising:
A method for fabricating a swallowable intragastric balloon system, the method comprising:
A method for inflating a swallowable intragastric balloon, comprising:
Dependencies are inferred from the claim text.